By Goldstone, A. H., Richards, S. M., Lazarus,...
The survival difference was significant in standard-risk patients, but
not in high-risk patients with a high nonrelapse mortality rate in the
high-risk donor group. Patients randomized to chemotherapy had a higher
5-year OS (46%) than ...
<http://bloodjournal.hematologylibrary.org/cgi/content/short/111/4/1827?rss=1>
Blood current issue
<http://bloodjournal.hematologylibrary.org>
This as-it-happens Google Alert is brought to you by Google...
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Remove this Google Alert:
http://www.google.com/alerts/remove?s=EAAAAMxW0yXFSvVDisVd6G88-5Y&hl=en
Create another Google Alert:
http://www.google.com/alerts?hl=en
Sign in to manage your alerts:
http://www.google.com/alerts/manage?hl=en
No comments:
Post a Comment